Back
Pharming Group NV Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
PHAR
Pharming Group NV
Last Price:
$16.53
Seasonality Move:
-4.54%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAR is experiencing slight buying pressure.
Pharming Group NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.58 | Sell |
| 20-day SMA: | 16.79 | Sell |
| 50-day SMA: | 17.5 | Sell |
| 200-day SMA: | 14.18 | Buy |
| 8-day EMA: | 13.75 | Buy |
| 20-day EMA: | 8.37 | Buy |
| 50-day EMA: | 4.06 | Buy |
| 200-day EMA: | 1.12 | Buy |
Pharming Group NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.53 | Buy |
| Relative Strength Index (14 RSI): | 44.33 | Sell |
| Chaikin Money Flow: | 10234 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.62 - 19.4) | Sell |
| Bollinger Bands (100): | (14.65 - 18.29) | Sell |
Pharming Group NV Technical Analysis
| Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 12 | 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pharming Group NV Stock
Is Pharming Group NV Stock a Buy?
-
Pharming Group NV share price is 16.37 while PHAR 8-day simple moving average is 16.58, which is a Sell signal.
-
The stock price of PHAR is 16.37 while Pharming Group NV 20-day SMA is 16.79, which makes it a Sell.
-
Pharming Group NV 50-day simple moving average is 17.50 while PHAR share price is 16.37, making it a Sell technically.
-
PHAR stock price is 16.37 and Pharming Group NV 200-day simple moving average is 14.18, creating a Buy signal.
PHAR Technical Analysis vs Fundamental Analysis
Sell
32
Pharming Group NV (PHAR)
is a Sell
Is Pharming Group NV a Buy or a Sell?
-
Pharming Group NV stock is rated a SellThe current Pharming Group NV [PHAR] share price is $16.37. The Score for PHAR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Pharming Group NV Stock Info
Market Cap:
1.1B
Price in USD:
16.37
Share Volume:
23.5K
Pharming Group NV 52-Week Range
52-Week High:
21.34
52-Week Low:
7.50
Sell
32
Pharming Group NV (PHAR)
is a Sell
Pharming Group NV Share Price Forecast
-
What is the Pharming Group NV stock price today?The Pharming Group NV stock price is 16.37 USD today.
-
Will PHAR stock go up or go down?Pharming Group NV> share price is forecast to RISE/FALL based on technical indicators
-
Is Pharming Group NV overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pharming Group NV is overvalued.
Is Pharming Group NV Stock a Buy?
-
Pharming Group NV share price is 16.37 while PHAR 8-day exponential moving average is 13.75, which is a Buy signal.
-
The stock price of PHAR is 16.37 while Pharming Group NV 20-day EMA is 8.37, which makes it a Buy.
-
Pharming Group NV 50-day exponential moving average is 4.06 while PHAR share price is 16.37, making it a Buy technically.
-
PHAR stock price is 16.37 and Pharming Group NV 200-day simple moving average is 1.12, creating a Buy signal.
Fundamental Analysis of Pharming Group NV
Is Pharming Group NV a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Pharming Group NV
Should I short Pharming Group NV stock?
-
PHAR Moving Average Covergence Divergence (MACD) indicator is 4.53, suggesting Pharming Group NV is a Buy
-
Pharming Group NV Relative Strength Index (RSI) is 44.33, which suggest Pharming Group NV is oversold
-
The Bollinger Bands (25) for Pharming Group NV is (15.62 - 19.4), which suggest Pharming Group NV is a Sell
-
The Bollinger Bands (100) for Pharming Group NV is (14.65 - 18.29), which suggest Pharming Group NV is a Sell
* Pharming Group NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.